Medexus Pharmaceuticals (TSX:MDP) Current Deferred Taxes Liabilities : C$0.0 Mil (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Medexus Pharmaceuticals Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Medexus Pharmaceuticals's current deferred tax liabilities for the quarter that ended in Dec. 2023 was C$0.0 Mil.

Medexus Pharmaceuticals Current Deferred Taxes Liabilities Historical Data

The historical data trend for Medexus Pharmaceuticals's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medexus Pharmaceuticals Current Deferred Taxes Liabilities Chart

Medexus Pharmaceuticals Annual Data

Trend

Dec13

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Medexus Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Medexus Pharmaceuticals Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Medexus Pharmaceuticals's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Medexus Pharmaceuticals (TSX:MDP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medexus Pharmaceuticals Inc (TSX:MDP) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

MEDXF:USA P731:Germany

Address

35 Nixon Road, Suite 1, Bolton, ON, CAN, L7E 1K1

Website

https://www.medexus.com

Medexus Pharmaceuticals Inc is an innovative and rare disease pharmaceutical company with a strong North American commercial platform and a portfolio of proven best-in-class products. The company's focus is on the therapeutic areas of hematology, auto-immune diseases, and allergy.

Executives

Benoit Gravel

Director